Categories Earnings, Technology
MongoDB (MDB) betters Q4 2020 estimates; Q1 and FY21 revenue to be affected by COVID-19
Coronavirus outbreak to impact MongoDB's Q1 and fiscal 2021 revenue
Despite surpassing the bottom and topline estimates of the Street in Q4, MongoDB (NASDAQ: MDB) stock traded in negative territory as the company said COVID-19 outbreak will negatively impact its revenue in Q1 2021 and fiscal 2021. After plunging to a new 52-week low yesterday, MDB stock bounced back and ended up 15.71% today. However, the stock dropped about 5% in the after-market trading.
The New York-based database developer’s Q4 2020 loss widened to $0.25 per share and revenue jumped 44% to $123.5 million. The market had estimated MongoDB to post a fourth-quarter loss of $0.28 per share and revenue of $110.57 million in Q4.
Atlas customers grew 35% annually to over 15,400 and customers with $100,000 or greater in annualized recurring revenue and annualized monthly recurring revenue rose to 751 from 557 in the last year.
Subscription revenue rose 46% year-over-year to $117.8 million and services revenue grew 17% to $5.7 million. On a GAAP basis, net loss was $62.6 million or $1.10 per share compared to a loss of $22.2 million or $0.41 per share in the prior-year quarter.
MongoDB expects fiscal 2021 non-GAAP loss to be in the range of $1.40 per share to $1.23 per share. Revenue is targeted to be between $510 million and $530 million.
For the first quarter of fiscal 2021, the company expects loss to be in the range of $0.25 per share to $0.22 per share on revenue of $119 million to $121 million.
The company estimates $1 million to $2 million negative revenue impact from COVID-19 outbreak for the first quarter and $15 million to $25 million for the full-year fiscal 2021. MongoDB added that the situation regarding COVID-19 is “uncertain” and is changing rapidly. MongoDB will continue to evaluate the global pandemic’s potential impact on its business.
MDB stock declined 34% in the past one month and 14% since the beginning of the year.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Comments